Trade Summary

2 days ago, Wai Conrad, serving as CEO, Counterpart Health at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 24,215 shares at $4.67 per share, for a total transaction value of $113,084.05. Following this transaction, Wai Conrad now holds 1,145,699 shares of CLOV.

This sale represents a 2.07% decrease in Wai Conrad's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, July 15, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 16, 2026 at 4:55 PM ET, 1 day after the trade was made.

CLOVER HEALTH INVESTMENTS, CORP. /DE operates in the HEALTHCARE sector, specifically within the HEALTHCARE PLANS industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.